Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSB-CAR001 in ACL Reconstruction
NCT01088191Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Mar 2009
- Primary completion
- Nov 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of rexlemestrocel-l in anterior cruciate ligament injury, osteoarthritis (OA), sponsored by Mesoblast Ltd. Started Mar 2009; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
anterior cruciate ligament injuryosteoarthritis (OA)
Beyond the preview
Go deeper on NCT01088191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088191.